NDC properties for "adalimumab-ryvk 80 MG per 0.8 ML Auto-Injector" (RxCUI 2706644)
About this data
The tables show NDC propoerties for adalimumab-ryvk 80 MG per 0.8 ML Auto-Injector with the RxCUI 2706644
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for adalimumab-ryvk 80 MG per 0.8 ML Auto-Injector (RxCUI 2706644)
| BLA | BLA761299 |
|---|---|
| RxCUI | 2706644 |
| SPL_SET_ID | 2d19a877-1f5a-4731-800a-dddadc424080 |
| Prescribable Synonym | adalimumab-ryvk 80 MG in 0.8 ML Auto-Injector |
| RXNAV_STR | 0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector |
| RxNorm Name | 0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector |
| RxNorm Synonym | adalimumab-ryvk 80 MG per 0.8 ML Auto-Injector |
| Related queries | Interactions (for RxCUI 2706644) |
NDC Properties
NDC Item 51759036103
| NDC 9 | 51759-361 |
|---|---|
| NDC 10 | 51759-361-03 |
| NDC Item | 51759036103 |
| Packaging | 3 KIT in 1 CARTON (51759-361-03) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * .4 mL in 1 POUCH |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-361 |
NDC Item 51759036117
| NDC 9 | 51759-361 |
|---|---|
| NDC 10 | 51759-361-17 |
| NDC Item | 51759036117 |
| Packaging | 1 KIT in 1 CARTON (51759-361-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * .4 mL in 1 POUCH |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-361 |
NDC Item 51759036103
| NDC 9 | 51759-361 |
|---|---|
| NDC 10 | 51759-361-03 |
| NDC Item | 51759036103 |
| Packaging | 3 KIT in 1 CARTON (51759-361-03) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * .4 mL in 1 POUCH |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-361 |
NDC Item 51759036117
| NDC 9 | 51759-361 |
|---|---|
| NDC 10 | 51759-361-17 |
| NDC Item | 51759036117 |
| Packaging | 1 KIT in 1 CARTON (51759-361-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * .4 mL in 1 POUCH |
| BLA | BLA761299 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2025-02-28 |
| Marketing status | active |
| Related queries | Properties for NDC 9 51759-361 |